The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-(bis(4-methoxyphenyl)methylene)hydrazinecarbonyl)-N-(4-(6-methoxyquinolin-8-ylamino)pentyl)hydrazinecarboxamide ID: ALA3330900
PubChem CID: 118713297
Max Phase: Preclinical
Molecular Formula: C32H37N7O5
Molecular Weight: 599.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(C(=NNC(=O)NNC(=O)NCCCC(C)Nc2cc(OC)cc3cccnc23)c2ccc(OC)cc2)cc1
Standard InChI: InChI=1S/C32H37N7O5/c1-21(35-28-20-27(44-4)19-24-8-6-17-33-30(24)28)7-5-18-34-31(40)37-39-32(41)38-36-29(22-9-13-25(42-2)14-10-22)23-11-15-26(43-3)16-12-23/h6,8-17,19-21,35H,5,7,18H2,1-4H3,(H2,34,37,40)(H2,38,39,41)
Standard InChI Key: UHBXFYHKZIWKRI-UHFFFAOYSA-N
Molfile:
RDKit 2D
44 47 0 0 0 0 0 0 0 0999 V2000
21.1831 -15.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8623 -15.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8623 -14.5842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1831 -14.1926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1831 -13.3676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4540 -12.9342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7289 -13.3676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7289 -14.1926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4540 -14.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4540 -15.4092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7289 -15.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9998 -15.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9998 -14.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4540 -12.1093 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1831 -11.7176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5914 -15.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3206 -15.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9997 -15.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7248 -15.4092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4539 -15.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1830 -15.4092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.8622 -15.8426 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5914 -15.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3163 -15.8426 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0455 -15.4092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7246 -15.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4538 -15.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1789 -15.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8621 -15.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8621 -14.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1789 -14.1926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4538 -14.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5872 -14.1926 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.3163 -14.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7246 -16.6675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0455 -17.0592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0455 -17.8842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7246 -18.3175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4538 -17.8842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4538 -17.0592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7246 -19.1425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.4538 -19.5342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5914 -14.5842 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4539 -16.6675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 9 1 0
11 10 2 0
12 11 1 0
13 12 2 0
8 13 1 0
6 14 1 0
14 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
30 33 1 0
33 34 1 0
26 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 35 1 0
38 41 1 0
41 42 1 0
23 43 2 0
20 44 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 599.69Molecular Weight (Monoisotopic): 599.2856AlogP: 4.81#Rotatable Bonds: 12Polar Surface Area: 147.23Molecular Species: NEUTRALHBA: 8HBD: 5#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.71CX Basic pKa: 4.06CX LogP: 3.78CX LogD: 3.77Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.09Np Likeness Score: -0.89
References 1. Pavić K, Perković I, Cindrić M, Pranjić M, Martin-Kleiner I, Kralj M, Schols D, Hadjipavlou-Litina D, Katsori AM, Zorc B.. (2014) Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity., 86 [PMID:25203780 ] [10.1016/j.ejmech.2014.09.013 ] 2. Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B.. (2018) Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity., 146 [PMID:29407988 ] [10.1016/j.ejmech.2018.01.062 ] 3. Pavić K, Perković I, Pospíšilová Š, Machado M, Fontinha D, Prudêncio M, Jampilek J, Coffey A, Endersen L, Rimac H, Zorc B.. (2018) Primaquine hybrids as promising antimycobacterial and antimalarial agents., 143 [PMID:29220797 ] [10.1016/j.ejmech.2017.11.083 ]